This review did not verify an NR or Niagen injection offer in Lafayette. It did identify Lafayette NAD+ IV advertising and a separate Boulder Niagen IM lead. That is a limit of the information reviewed, not proof that no Lafayette provider offers NR shots. A specific request still needs a specific answer.
If staying in Lafayette and receiving NR by injection are both priorities, keep both conditions in your inquiry. A reply about an infusion, an oral supplement or another city may be useful, but it changes the comparison. The table below preserves those differences so you can see which part of the request each advertisement addresses.
Separate Lafayette offers from the Boulder lead
The local entries support inquiries about NAD+ IV. The regional entry supports a different inquiry about Niagen IM in Boulder. None is a confirmation of a treatment appointment, an endorsement, or a finding that the service suits you.
For a wider geographic search, use the Colorado overview. Keep the city in your notes even when a company serves several communities; a chain name is not a branch confirmation.
| Actual place | Advertised ingredient / route | Price status | Unanswered question |
|---|---|---|---|
| Blue Sky Aesthetics: 1200 S Public Rd., Lafayette, CO 80026 | Power Hour: NAD+ on the IV menu | Starts at $325; included amount unspecified | What is the complete visit quote? NR or injection availability is not established here. |
| U.S. Mobile IV: advertised Lafayette coverage | NAD+ IV; mobile service, not a storefront | NAD+ quote unverified | Will it serve the exact address with the requested service? |
| Regional: Onus Boulder, 1035 Walnut Street, Boulder, CO 80302 | Niagen IV and IM; also NAD+ IV and IM | Product-specific quote needed | Can the Boulder branch confirm the requested NR visit? |
Make the product name precise
The Niagen manufacturer identifies its ingredient as nicotinamide riboside chloride, an NAD+ precursor, and separates prescription injectable formats from oral Tru Niagen supplements. NAD+ is the coenzyme itself. Manufacturer FAQ.
Try putting your request into three blanks: ingredient, route, city. If the answer fills only one or two, ask for the missing part. This avoids an unhelpful yes-or-no exchange in which you and the provider are discussing different services.
For example, an affirmative reply about an NAD+ infusion does not settle a request for an NR intramuscular injection. You can decide whether to explore the alternative, but label it as an alternative in your notes. The label-question guide can help you prepare terminology questions without supplying administration instructions.
Ask for a written description that answers the request
A short written reply is easier to compare than a broad reassurance. The worksheet focuses on missing identifiers rather than asking a provider to repeat its marketing. It also lets you pause an inquiry when the reply concerns a different product or setting.
| Ask for | How to use the answer |
|---|---|
| Exact ingredient and brand | Copy the written name. A general NAD+ category heading does not identify the requested product. |
| Administration route | Ask whether the proposal is IV, IM or another format. Do not translate a general injection label into a specific route. |
| Treating location or coverage | Record the city and address, or confirmation of your mobile address. A company-wide page does not settle a branch question. |
| Dispensing pharmacy and preparation | Ask who supplies the proposed medication and who can answer product questions. This review has not inspected a vial or pharmacy. |
| Complete visit quote | Request all included services and any payment commitment. Leave a missing figure blank rather than borrowing another menu price. |
Choosing where the conversation and visit happen
U.S. Mobile IV’s general Denver-area page mentions NAD+ IM, but it does not establish Lafayette-specific IM availability. General service page.
That distinction matters when the requested route is the reason for your inquiry. Ask for the route and address in the same reply. An answer confirming the location alone leaves the product question open.
The choice between a clinic, a mobile visit and an online evaluation also affects the questions to ask about responsibility. Who assesses the request, who would provide the service, and who handles later medical concerns? Describe the support you need before comparing convenience. Our local-or-online guide helps frame those preferences without assuming a particular service will be offered.
Compare only the service actually quoted
For the regional lead, Onus’s Niagen menu lists a 50 mg IM item at $125 standard or $87.50 member. Those amounts identify an advertised item, not a recommended dose; membership conditions and the Boulder visit total need confirmation. Niagen menu.
The Lafayette mobile page advertises no additional travel charge, but that is not a complete NAD+ quote or an address-specific guarantee. Coverage terms.
Ask what happens to the quote if the assessment leads to a different plan or no treatment. Keep optional purchases separate from the initial request, and ask when any recurring charge would begin. The cost guide provides a place to organize the answers. A written total is useful only when its ingredient, route and conditions remain attached.
Keep local availability separate from clinical evidence
Compounded drugs are not FDA-approved; registration does not make a preparation approved. FDA explanation. FDA’s sterile-ingredient warning does not make findings against these providers. FDA notice.
The compounding and approval guide explains the distinction. Ask the clinician which evidence concerns the exact proposed formulation and route, and what remains uncertain for your goal. A provider listing answers an availability question, not an outcomes question.
For a fuller discussion of the small IV studies and their limits, read the Denver comparison. Keep that research discussion separate from your locality requirement: evidence does not establish where an appointment can be obtained, and a local advertisement does not establish benefit.
Nearby places and geographic context
The map uses 2025 Census Gazetteer reference points. These are communities, not verified clinic locations. Distances are straight-line estimates from Lafayette; they do not show driving routes or treatment availability.
Geographic schematic, not a road map. Numbers match the nearby-place list. Locations use Census internal points; distances are straight-line estimates, not travel times.
Questions and answers
Did this review verify Niagen or NR shots in Lafayette?
No. The reviewed material did not establish that particular local offer. This is a bounded finding about the information available here, not a claim that the service cannot exist. A provider’s written confirmation of ingredient, route and Lafayette location would address the unresolved question.
Is an NAD+ IV listing the same service?
No. It describes a different requested ingredient-and-route combination. Treat the listing as a separate option to discuss rather than an answer to an NR shot request. Whether an alternative is appropriate is a question for the evaluating clinician, not something a shared category name resolves.
What documented Boulder lead can I investigate?
The Onus Boulder branch page lists Niagen IM. It is a regional lead in Boulder, not a Lafayette location. Confirm the proposed visit with that branch and keep any travel preference separate from questions about the medication and care.
What should the written quote and product description include?
Request the ingredient, formulation, route, actual service location, dispensing pharmacy and complete charge. Add any membership commitment and the terms if treatment is declined after assessment. A reply that omits a requested identifier is a reason for a follow-up question, not a basis for filling the gap yourself.
Primary sources and document dates
- Blue Sky IV menu · Checked 2026-11-05
- U.S. Mobile IV Lafayette · Checked 2026-11-05
- Onus Boulder location · Checked 2026-11-05
- Niagen product FAQ · Checked 2026-11-05
- U.S. Mobile IV NAD+ · Checked 2026-11-05
- Onus Niagen menu · Checked 2026-11-05
- FDA compounding questions · Checked 2026-11-05
- FDA sterile ingredients notice · Checked 2026-11-05